Sandbox chemo1: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 112: | Line 112: | ||
====== Progestins ====== | ====== Progestins ====== | ||
* [[Medroxyprogesterone | * [[Medroxyprogesterone|Medroxyprogesterone (Provera)]] | ||
* [[Megestrol|Megestrol (Megace)]] | * [[Megestrol|Megestrol (Megace)]] | ||
| Line 139: | Line 139: | ||
===== GnRH agonists ===== | ===== GnRH agonists ===== | ||
* [[Buserelin|Buserelin (Superfact)]] | * [[Buserelin|Buserelin (Superfact)]] | ||
* [[Goserelin|Goserelin (Zoladex)]] | * [[Goserelin|Goserelin (Zoladex)]] | ||
* [[Leuprolide|Leuprolide (Lupron)]] | * [[Leuprolide|Leuprolide (Lupron)]] | ||
===== GnRH antagonists ===== | ===== GnRH antagonists ===== | ||
*[[Degarelix|Degarelix (Firmagon)]] | * [[Degarelix|Degarelix (Firmagon)]] | ||
---- | ---- | ||
=== Biologics === | |||
===== Monoclonal antibodies ===== | ===== Monoclonal antibodies ===== | ||
| Line 162: | Line 162: | ||
====== Anti-CD20 antibodies ====== | ====== Anti-CD20 antibodies ====== | ||
* [[Rituximab|Rituximab (Rituxan)]] | * [[Rituximab|Rituximab (Rituxan)]] | ||
====== Anti-CD30 antibodies ====== | |||
*[[Brentuximab|Brentuximab (Adcetris)]] | |||
====== Anti-CD33 antibodies ====== | ====== Anti-CD33 antibodies ====== | ||
* [[Gemtuzumab|Gemtuzumab (Mylotarg)]] | * [[Gemtuzumab|Gemtuzumab (Mylotarg)]] | ||
====== Anti-CD52 antibodies ====== | ====== Anti-CD52 antibodies ====== | ||
* [[Alemtuzumab|Alemtuzumab (Campath)]] | |||
====== Anti-EGFR (ErbB1) antibodies ====== | ====== Anti-EGFR (ErbB1) antibodies ====== | ||
* [[Cetuximab|Cetuximab (Erbitux)]] | * [[Cetuximab|Cetuximab (Erbitux)]] | ||
* [[Panitumumab|Panitumumab (Vectibix)]] | |||
===== Anti-HER2/neu (ErbB2) antibodies ===== | |||
*[[Ado-trastuzumab emtansine|Ado-trastuzumab emtansine (Kadcyla)]] | *[[Ado-trastuzumab emtansine|Ado-trastuzumab emtansine (Kadcyla)]] | ||
*[[Trastuzumab|Trastuzumab (Herceptin)]] | *[[Trastuzumab|Trastuzumab (Herceptin)]] | ||
===== | ====== Anti-VEGF antibodies ====== | ||
*[[ | * [[Bevacizumab|Bevacizumab (Avastin)]] | ||
===== IL-2 inhibitors ===== | ===== IL-2 inhibitors ===== | ||
* [[Aldesleukin|Aldesleukin (Proleukin)]] | * [[Aldesleukin|Aldesleukin (Proleukin)]] | ||
* [[Denileukin diftitox|Denileukin diftitox (Ontak)]] | * [[Denileukin diftitox|Denileukin diftitox (Ontak)]] | ||
===== IL-6 inhibitors ===== | |||
*[[Siltuximab|Siltuximab (Sylvant)]] | |||
===== Immunotherapy ===== | ===== Immunotherapy ===== | ||
| Line 199: | Line 195: | ||
---- | ---- | ||
=== Hematopoietic Growth Factors === | |||
===== Erythrocyte growth factors ===== | ===== Erythrocyte growth factors ===== | ||
Revision as of 21:53, 23 February 2015
Chemotherapeutic Agents by Category
Alkylating agents
Nitrogen mustards
- Chlorambucil (Leukeran)
- Cyclophosphamide (Cytoxan)
- Ifosfamide (Iflex)
- Melphalan (Alkeran)
- Mechlorethamine (Mustargen)
Ethylenimines
Methylhydrazines
Alkylsulfonates
Nitrosoureas
Triazenes
Platinum coordination complexes
Antimetabolites
Folic acid analogs
Pyrimidine analogs
- Azacytidine (Vidaza)
- Capecitabine (Xeloda)
- Cytarabine (Cytosar)
- Floxuridine (FUDR)
- Fluorouracil (Adrucil, Efudex)
- Gemcitabine (Gemzar)
Purine analogs
- Cladribine (Leustatin)
- Clofarabine (Clolar)
- Fludarabine (Fludara)
- Mercaptopurine (Purinethol)
- Nelarabine (Arranon)
- Pentostatin (Nipent)
- Thioguanine (Tabloid)
Ribonucleotide reductase inhibitors
Natural products
Vinca alkaloids
- Vinblastine (Velban, Velsar)
- Vincristine (Oncovin, Vincasar)
- Vincristine liposome (Marqibo)
- Vinorelbine (Navelbine)
Taxanes
Epipodophyllotoxins
Camptothecins
Antineoplastic antibiotics
- Bleomycin (Blenoxane)
- Dactinomycin (Cosmegen)
- Daunorubicin (Daunoxome)
- Doxorubicin (Adriamycin, Rubex)
- Epirubicin (Ellence)
- Idarubicin (Idamycin)
- Mitomycin C (Mutamycin)
- Mitoxantrone (Novantrone)
- Valrubicin (Valstar)
Antineoplastic enzymes
Hormones and Antagonists
Adrenocortical suppressants
Adrenocortico-steroids
Progestins
Anti-estrogens
Aromatase inhibitors
Androgens
Anti-androgens
- Abiraterone (Zytiga)
- Bicalutamide (Casodex)
- Dutasteride (Avodart)
- Enzalutamide (Xtandi)
- Flutamide (Eulexin)
- Finasteride (Proscar)
- Ketoconazole (Nizoral)
- Nilutamide (Nilandron)
- Triptorelin (Trelstar)
GnRH agonists
GnRH antagonists
Biologics
Monoclonal antibodies
- Altretamine (Hexalen)
- Denosumab (Xgeva)
- Ibritumomab tiuxetan (Zevalin)
- Ipilimumab (Yervoy)
- Nivolumab (Opdivo)
- Obinutuzumab (Gazyva)
- Ofatumumab (Arzerra)
- Pembrolizumab (Keytruda)
Anti-CD20 antibodies
Anti-CD30 antibodies
Anti-CD33 antibodies
Anti-CD52 antibodies
Anti-EGFR (ErbB1) antibodies
Anti-HER2/neu (ErbB2) antibodies
Anti-VEGF antibodies
IL-2 inhibitors
IL-6 inhibitors
Immunotherapy
Hematopoietic Growth Factors
Erythrocyte growth factors
Granulocyte growth factors
Megakaryocyte growth factors
Supportive Medications
Chemotherapy protective agents
- Amifostine (Ethyol)
- Cyanocobalamin
- Dexrazoxane (Zinecard)
- Folinic acid (Leucovorin)
- Glucarpidase (Voraxaze)
- Levoleucovorin (Fusilev)
- Mesna (Mesnex)
Antiemetic agents
RANK ligand inhibitors
Miscellaneous
Antimitotic agent
Bisphosphonate
HDAC inhibitors
Hedgehog pathway inhibitors
Immunomodulatory drugs (IMiDs)
Kinase inhibitors
- Afatinib (Gliotrif)
- Cabozantinib (Cometriq)
- Crizotinib (Xalkori)
- Dasatinib (Sprycel)
- Erlotinib (Tarceva)
- Gefitinib (Iressa)
- Ibrutinib (Imbruvica)
- Idelalisib (Zydelig)
- Lapatinib (Tykerb)
- Nilotinib (Tasigna)
- Palbociclib (Ibrance)
- Sorafenib (Nexavar)
- Sunitinib (Sutent)